Infliximab for the treatment of intravenous immunoglobulin resistant Kawasaki disease complicated by coronary artery aneurysms: a case report

doi:10.1186/1546-0096-7-3

Pediatric Rheumatology

Volume 7

Viewing options:

Abstract
Full text
PDF (292KB)

Associated material:

Related literature:

Articles citing this article
on Google Scholar
on ISI Web of Science
on PubMed Central
Other articles by authors
on Google Scholar

Brogan RJ
Eleftheriou D
Gnanapragasam J
Klein NJ
Brogan PA

on PubMed

Brogan RJ
Eleftheriou D
Gnanapragasam J
Klein NJ
Brogan PA
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Case Report

Infliximab for the treatment of intravenous immunoglobulin resistant Kawasaki disease complicated by coronary artery aneurysms: a case report

Robert J Brogan¹ , Despina Eleftheriou¹ , James Gnanapragasam² , Nigel J Klein³ and Paul A Brogan¹

¹Department of Paediatric Rheumatology, UCL Institute of Child Health and Great Ormond Street Hospital, 30 Guilford Street, London, UK

²Congenital Cardiac Centre, North Wing, Southampton University Hospitals NHS Trust, Tremona Road, Southampton, UK

³Department of Infectious disease and Microbiology, UCL Institute of Child Health and Great Ormond Street Hospital, 30 Guilford Street, London, UK

author email corresponding author email

Pediatric Rheumatology 2009, 7:3doi:10.1186/1546-0096-7-3


Published:	21 January 2009

Abstract

This case report describes an 8 year old boy with IVIG resistant Kawasaki disease complicated by severe bilateral coronary artery aneurysms successfully treated with infliximab, a monoclonal antibody against tumour necrosis factor alpha.